Health ❯ Healthcare ❯ Pharmaceuticals ❯ Cancer Treatment

Multiple Myeloma

FDA Clears Wearable Injector Form of Sanofi’s Multiple Myeloma Drug

The approval should shorten infusion time for patients and position Sanofi to expand how it delivers cancer therapies.

Pfizer’s Elrexfio Posts Phase 3 PFS Win Over Standard Multiple Myeloma Regimen

Tecvayli Cuts Progression Risk 71% and Deaths 40% in Phase 3 Myeloma Trial

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

J&J Myeloma Trial Stopped Early After Tecvayli–Darzalex Shows PFS and OS Benefit